Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1481646/000155837022006561/accd-20220228x10k.htm
April 2022
January 2022
October 2021
July 2021
July 2021
June 2021
June 2021
June 2021
April 2021
March 2021
Exhibit 99.1
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2022
● | Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 million |
● | Fiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million |
SEATTLE, April 28, 2022 -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 28, 2022.
“Fiscal year 2022 represented a transformational time for Accolade. Our strong financial results validate the strategic moves we made to deliver Personalized Healthcare through both internal innovation and bold acquisitions. Today, our customers and prospects look to Accolade to solve a far more comprehensive set of healthcare challenges, as they look to empower their employees by delivering a superior healthcare experience that is personal, data-driven and value-based,” said Rajeev Singh, Accolade Chief Executive Officer.
“The pipeline for new business is stronger than it has ever been. While we are seeing early selling season momentum across market segments and various industry verticals, market dynamics continue to evolve rapidly in our space. This month, a large customer notified us that they would be ending their service relationship with us after the end of calendar 2022. Coupling this event with the broader macro-environment, we are moderating our top line growth objectives and improving our path to profitability, while continuing to focus on delivering exceptional personalized healthcare services to our customers and the families of their employees. As the leader in the market for personalized healthcare with an unmatched track record of performance, industry leading customers across sectors, and a strong balance sheet, we are well positioned to maintain our discipline and emerge from this period even stronger than we entered.”
Financial Highlights for Fiscal Fourth Quarter and Fiscal Year ended February 28, 2022
| | Three Months Ended February 28, | | % |
| | Twelve Months Ended February 28, | | % |
| ||||||||
|
| 2022 |
| 2021 |
| Change(2) |
| | 2022 |
| 2021 |
| Change(2) |
| ||||
| | (in millions, except percentages) | | |
| | (in millions, except percentages) | | |
| ||||||||
GAAP Financial Data: | | | | | | | | | | | | | | | | | | |
Revenue | | $ | 93.8 | | $ | 59.2 | | 58 | % | | $ | 310.0 | | $ | 170.4 | | 82 | % |
Net Loss | | $ | (34.6) | | $ | (4.7) | | (631) | % | | $ | (123.1) | | $ | (50.7) | | (143) | % |
| | | | | | | | | | | | | | | | | | |
Non-GAAP Financial Data(1): | | | | | | | | | | | | | | | | | | |
Adjusted EBITDA | | $ | 1.8 | | $ | 2.7 | | (34) | % | | $ | (42.4) | | $ | (26.9) | | (57) | % |
Adjusted Gross Profit | | $ | 51.0 | | $ | 31.9 | | 60 | % | | $ | 144.2 | | $ | 77.6 | | 86 | % |
Adjusted Gross Margin | | | 54.4 | % | | 53.8 | % | | | | | 46.5 | % | | 45.6 | % | | |
(1) A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying Financial Tables. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."
(2) Percentages are calculated from accompanying Financial Tables and may differ from percentage change of numbers in Financial Highlights table due to rounding.
Steve Barnes, Accolade Chief Financial Officer, commented, “The fourth quarter of fiscal year 2022 marked the eighth straight quarter of exceeding our financial targets since our IPO in July 2020. We have delivered that consistency by being highly cognizant of the environment we operate in, and planning our business accordingly. It is in that context that we are adjusting our expectations for top line growth while continuing to reduce our Adjusted EBITDA loss consistently as we
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1481646/000155837022006561/accd-20220228x10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Accolade, Inc..
Accolade, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More![]()
In addition, because our customers typically pay both the base PMPM fees and variable PMPM fees in advance on a periodic basis, any required refund as a result of our failure to earn the performance-based revenue could have a negative impact on cash flows.
The following table presents, for the periods indicated, the calculation of our Adjusted Gross Profit and Adjusted Gross Margin: Gross margin, excluding depreciation and amortization, for fiscal 2022 increased to 45.5% from 45.0% for fiscal 2021 and Adjusted Gross Margin for fiscal 2022 increased to 46.5% from 45.6% for fiscal 2021.
By leveraging our technology in areas such as machine learning, predictive analytics, and multimodal communication, we believe we can generate more efficiencies in our operating model while simultaneously improving our ability to deliver better health outcomes and lower costs for both our members and our customers.
We have chosen to invest significantly in growing our customer base, and plan to continue both adding new customers and expanding our relationships with existing customers, which we believe will allow us to increase margins over time.
We believe that our platform dramatically improves the member experience, encourages better health outcomes, and lowers costs for both our members and our customers.
These non-GAAP financial measures may...Read more
When evaluating our performance, you...Read more
The following factors have been...Read more
Our cost of revenue, excluding...Read more
We plan to continue to...Read more
Product and technology expenses consist...Read more
We believe Adjusted EBITDA provides...Read more
We may issue up to...Read more
The following table summarizes our...Read more
During March 2020, we borrowed...Read more
Interest expense, net decreased $0.8...Read more
Net cash provided by financing...Read more
Net cash used in investing...Read more
Different offering configurations may also...Read more
Accolade One - A value-based...Read more
In addition, unanticipated events and...Read more
MD and PlushCare acquisitions, digital...Read more
We believe the effectiveness of...Read more
Generally, we satisfy these performance...Read more
Variances in these assumptions could...Read more
Any reduction in the useful...Read more
The fees associated with the...Read more
In some cases, especially with...Read more
We typically achieve a substantial...Read more
As we support more customers...Read more
We have demonstrated a consistent...Read more
Gross Dollar Retention Rate (GDR)...Read more
For the fiscal years ended...Read more
We believe Adjusted Gross Profit...Read more
As a result, generally, a...Read more
Adjusted EBITDA is a non-GAAP...Read more
Accordingly, we determine revenue recognition...Read more
The majority of fees earned...Read more
Annual Contract Value (ACV) -...Read more
The ACV amounts included above...Read more
We earn revenue from providing...Read more
The following table presents a...Read more
Based on the market value...Read more
Factors that might cause future...Read more
We believe a measure of...Read more
With these changes, our current...Read more
In most of our contracts,...Read more
Depreciation and amortization expense increased...Read more
We believe that as we...Read more
Advocacy customers ACV for advocacy...Read more
Our contracts include stand-ready services...Read more
Our sales team possesses deep...Read more
We have seen significant growth...Read more
We maintain relationships with a...Read more
Goodwill represents the excess of...Read more
Our innovative platform combines open,...Read more
Material Cash Requirements As of...Read more
Any investments we make in...Read more
As a result, a portion...Read more
We earn revenue from providing...Read more
Although we have earned over...Read more
Our open technology platform also...Read more
We measure our performance through...Read more
The increase was attributable primarily...Read more
We use the following non-GAAP...Read more
Our PMPM pricing varies by...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Accolade, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ACCD
CIK: 1481646
Form Type: 10-K Annual Report
Accession Number: 0001558370-22-006561
Submitted to the SEC: Mon May 02 2022 6:04:59 AM EST
Accepted by the SEC: Mon May 02 2022
Period: Monday, February 28, 2022
Industry: Business Services